#ICYMI - Steven Robinson, MBBS, of Mayo Clinic, leads Alliance trial A092107 that compares the effect of treatment with palbociclib alone to treatment with palbociclib plus cemiplimab for treating patients with advanced dedifferentiated liposarcoma. Learn more, visit https://lnkd.in/gk6jK7yz #NCI #NCTN #SarcomaAwarnessMonth
Alliance for Clinical Trials in Oncology
Research Services
Chicago, IL 9,757 followers
Reducing the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines.
About us
The Alliance for Clinical Trials in Oncology is a national clinical trials network sponsored by the National Cancer Institute (NCI) that consists of nearly 10,000 cancer specialists at hospitals, medical centers, and community clinics across the United States and Canada. The Alliance is dedicated to developing and conducting clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as researching methods to alleviate side effects of cancer and cancer treatments. The Alliance is a member of the NCI National Clinical Trials Network (NCTN) and also serves as a research base for the NCI Community Research Oncology Program (NCORP). The Alliance seeks to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer. Our mission is three-fold: To conduct high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network; To further our understanding of the biological basis of the cancer process and its treatment, from discovery, to validation, to clinical practice; and To provide a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings.
- Website
-
http://www.AllianceNCTN.org
External link for Alliance for Clinical Trials in Oncology
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Chicago, IL
- Type
- Nonprofit
- Founded
- 2011
- Specialties
- Cancer Research , Cancer Control, Cancer Prevention , Cancer Treatment, Research Network, Clinical Practice, Clinical Research, Translational Research , and Clinical Trials
Locations
-
Primary
125 S. Wacker Drive, Suite 1600,
Chicago, IL 60606, US
-
221 Longwood Avenue, Room 108
Boston, MA 02115, US
Employees at Alliance for Clinical Trials in Oncology
-
Lisa Pitler
Healthcare Compliance Professional | Healthcare Regulatory Attorney | Research & Research Administration
-
Trinidad Ajazi
Chief Operating Officer
-
Stacy Reeves (Rogers), MBA, MPH
Clinical Research Operations
-
Lisa Mickolayck, MPH
Senior Translational Research Program Coordinator
Updates
-
For #TrialTuesday, Alliance A022106/PLATINUM trial, led by Dr. Andrew Ko, of UCSF Helen Diller Family Comprehensive Cancer Center, compares two chemotherapy regimens to treat patients with metastatic #pancreaticcancer and BRCA1/2 or PALB2 gene mutation. To learn more about the PLATINUM trial, visit https://lnkd.in/gq9nYKxM #NCI #NCTN Pancreatic Cancer Action Network Let's Win Pancreatic Cancer #PancChat #PancSM
-
-
For #TrialTuesday, #ComboMATCH Treatment Trial A3, led by Geoffrey Shapiro, MD, PhD, of Dana-Farber Cancer Institute, is evaluating the effectiveness of palbociclib and binimetinib in treating patients with RAS-mutated cancers. To learn more, visit https://bit.ly/cmatch-A3 #PrecisionMedicine #NCI #NCTN
-
-
For #TrialTuesday, take a look at the Alliance A222101 trial led by Elizabeth Cathcart-Rake, MD (Mayo Clinic). This trial tests safety, side effects, and the best dose of GM1 and if it works to reduce or prevent chemotherapy-induced peripheral #neuropathy in patients with metastatic #breastcancer who receive treatment with paclitaxel. To learn more, visit https://lnkd.in/gUMZAwVV #NCI #NCORP #CancerResearch
-
-
For #TrialTuesday, learn more about the JANUS trial (Alliance A022104) led by J. Josh Smith, MD, PhD, of Memorial Sloan Kettering Cancer Center. This trial aims to compare the effect of irinotecan versus oxaliplatin after long-course chemoradiation in patients with stage II-III #rectalcancer. Visit https://lnkd.in/gMK4_ibj #NCI #NCTN
-
-
ALCHEMIST trials are a group of studies seeking to improve treatment of patients with early stage non-small cell #lungcancer (NSCLC) whose tumors have been completely removed by surgery. Learn more about Alliance A151216 and A081801, visit https://bit.ly/ALCHEMIST24 #NCI #NCTN
-
-
#DYK: Dr. Neha Mehta-Shah, of Washington University in St. Louis, leads the Alliance A051902 trial to see how duvelisib and usual chemotherapy of cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone work to treat patients with peripheral T-cell #lymphoma: https://lnkd.in/dDAbUsv #NCI #NCTN #LYMsm
-
-
For #TrialTuesday, Dr. Andrew Ko, of UCSF Helen Diller Comprehensive Cancer Center, leads the Alliance A022106/PLATINUM trial to compare two chemotherapy regimens to treat patients with metastatic pancreatic cancer and BRCA1/2 or PALB2 gene mutation. To learn more about the PLATINUM trial, visit https://lnkd.in/gq9nYKxM #NCI #NCTN #PancChat #PancSM #CCDR
-
-
It's a wrap on an exciting four-day meeting! THANK YOU to everyone participating in the 2024 Alliance Spring Hybrid Group Meeting. Your remarkable efforts continue to advance cancer research. See you again in the fall - October 30-November 2. Stay well! #AllianceSpring24 #NCI #NCTN #NCORP
-
-
Welcome to Day 4 – Learn about myeloMATCH MSRP: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study. Sessions on this master screening and reassessment protocol start at 9a CT and 10a CT. #AllianceSpring24 #NCI #NCTN
-